Insulet to Halt Study of Omnipod Horizon Due to Software Anomaly

Shots:

• Insulet will pause the pivotal clinical study of its wearable insulin pump Omnipod Horizon automated glucose control system due to software bug. The company anticipates the availability of updated software by the end of Apr’2020
• The software glitch in the system may result in incorrect glucose value calculation which has the potential to impact insulin delivery. No adverse events have been reported due to this issue
• The Omnipod insulin management system with its wearable design and disposable Pod provides up to three days of non-stop insulin delivery without the need of handling the needle with its expected availability in the market H1’21

Click here ­to­ read full press release/ article | Ref: Insulet | Image: Myomnipod